Egrifta F8 water issueIt was supposed to be resolved in early October. What might TH say about this soon? Full speed ahead on F8 I imagine. But if cancer is looking promising, might they just extend the time-out on F8? I doubt it as it is part of the requirements for t he financing deal and would make Egrifta in Lipo more attractive to patients even if TH does not go forward with NASH. But, TH is giving no indications of giving up on NASH even though it has beenpassed over several times now in partnership deals.